Answers are grounded in this paper and cite their sources.
Previously unreported N-terminal hydantoin and N-acetyl hydantoin impurities were observed during peptide N-terminal acetylation with acetic anhydride under commonly used base/solvent conditions. The impurities were isolated and structurally characterized by HRMS and NMR. Systematic studies revealed pronounced solvent dependence and sequence sensitivity and identified conditions that suppressed their formation. Isotope-labeling experiments excluded acetic anhydride as the source of the carbonyl moiety incorporated into the hydantoin and supported solvent participation in the byproduct-forming pathway. Collectively, these results define an unexpected side reaction in widely used acetylation chemistry and provide practical guidance for impurity control in peptide synthesis and process development.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: